Steffen Armin, Hartmann Julia T, König Inke R, Ravesloot Madeline J L, Hofauer Benedikt, Heiser Clemens
Department of Otorhinolaryngology, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Institute of Medical Biometry and Statistics, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Sleep Breath. 2018 Dec;22(4):1207-1212. doi: 10.1007/s11325-018-1716-5. Epub 2018 Sep 5.
The definition of positional obstructive sleep apnea (POSA) is widely accepted as a difference of 50% or more in AHI between supine and non-supine position. Upper airway stimulation (UAS) is an effective treatment for OSA but the implant delivers a single voltage over sleep period without consideration of body position. Clinical practice suggests different outcomes for OSA in supine position under UAS treatment.
Outcomes of 44 patients were analyzed 12 months after implantation in a two-center, prospective consecutive trial in a university hospital setting. Total night and supine AHI were evaluated and the ratio of time spent in supine was considered. Correlation between the classic and the modified definition of POSA and treatment response were evaluated.
The time ratio spent in supine position did not differ before implantation and after 12 months. Total and supine AHI were reduced with the use of UAS therapy (p < 0.001) but both the baseline and final supine AHI were higher than total night AHI. Considering POSA definition as a ratio of supine to non-supine AHI, there was no clear cutoff for defining responders neither with nor without the additional component of time in supine position.
The OSA reduction is strong for the total AHI and supine AHI. Nonetheless, here, there is no cutoff for defining POSA as critical for UAS therapy response. Therefore, there is no evidence for excluding POSA patients from UAS in general. Future technology improvement should take body position and adaptive voltage into account.
体位性阻塞性睡眠呼吸暂停(POSA)的定义被广泛接受为仰卧位和非仰卧位之间的呼吸暂停低通气指数(AHI)差异达50%或更多。上气道刺激(UAS)是治疗阻塞性睡眠呼吸暂停(OSA)的一种有效方法,但该植入装置在睡眠期间施加单一电压,未考虑体位因素。临床实践表明,UAS治疗下仰卧位OSA患者的治疗效果各异。
在一所大学医院环境中进行的一项两中心、前瞻性连续试验中,对44例患者植入装置12个月后的治疗结果进行分析。评估了整夜和仰卧位的AHI,并考虑了仰卧位的时长占比。评估了POSA的经典定义和改良定义与治疗反应之间的相关性。
仰卧位的时长占比在植入前和12个月后无差异。使用UAS治疗后,总的和仰卧位的AHI均降低(p < 0.),但仰卧位AHI的基线值和最终值均高于整夜AHI。将POSA定义为仰卧位与非仰卧位AHI的比值时,无论是否加入仰卧位时长这一额外因素,均没有明确的临界值来界定反应者。
总的AHI和仰卧位AHI的OSA降低幅度很大。然而,在此研究中,没有临界值可将POSA定义为对UAS治疗反应至关重要。因此,总体而言,没有证据表明应将POSA患者排除在UAS治疗之外。未来的技术改进应考虑体位和自适应电压因素。